Healthcare
Entero Healthcare Solutions Limited
Who owns Entero Healthcare Solutions Limited?
The promoter group held 52.40% of Entero Healthcare at 30 September 2026, led by Orbimed Asia III Mauritius Limited (38.00%). Public shareholders held 47.60%.3 Filed categories do not identify every ultimate beneficial owner.
What the company does
Distributes pharmaceutical and health-care products to pharmacies and hospitals.
- Official website
- www.enterohealthcare.com
- Headquarters
- Faridabad, Haryana (registered office city)
- Registered office
- Plot No. I-35 Building - B, Industrial Area Phase -I, 13/7 Mathura Road,, Faridabad, 121003, Haryana, India Address source
- Country of incorporation
- India
- Corporate Identity Number
- L74999HR2018PLC0722042
- Incorporated
- 2018 · Public limited company
- LEI
- 335800JIMRC57GVQFT506
- Exchange identifiers
- NSE ENTERO · BSE 544122 · ISIN INE0106010162
A shareholder category in this filed snapshot; it is not an individual beneficial owner.
What the disclosure establishes
Filed categories are not individual beneficial owners. Promoter and public categories do not, by themselves, establish ultimate economic ownership or voting control. Named holders below are subsets of those categories.
Scope. Shareholding pattern dated 30 September 2026. A = promoter group; B = public; C2 = employee trusts. Percentages use the (A+B+C2) denominator. Categories are not identified people and are not evidence of ultimate beneficial control.
Ownership composition
Aggregate shareholder categories; not individual beneficial owners.
Inside the public category
Table III sub-totals
| Sub-category | Holding |
|---|---|
| Domestic institutions (B1) | 21.16% |
| Foreign institutions, incl. FPIs (B2) | 5.77% |
| Central and state governments (B3) | 0.00% |
| Non-institutional shareholders (B4) | 20.67% |
Sub-totals of the 47.60% public category in the same filing.4
Dated disclosures in the Atlas
2 observations
Data, history and downloads
Machine-readable record
| From → to | Promoter | Public | Employee trusts |
|---|---|---|---|
| 2026-06-30 → 2026-09-30 | 0.00 pp | 0.00 pp | 0.00 pp |
Differences between the filed category percentages of consecutive dated disclosures, in percentage points. Earlier disclosures are kept unchanged.
Original exchange disclosures are linked above and remain the authoritative record. The files below are The Raisina Post’s compilation of them: JSON · CSV · Markdown. Last modified 2026-10-21. See the dataset method and limitations.
Compare with other companies in Healthcare.
Original filing and record context
- Original source
- NSE XBRL shareholding pattern (SEBI LODR Reg. 31) for ENTERO · 30 September 2026 · Table I summary
- Observation date
- 2026-09-30
- Filed with the exchange
- 2026-10-21
- Verification
- Category totals match in the BSE and NSE copies of this filing
- Disclosure type
- Aggregate categories, with named holders shown separately
- Atlas entity ID
- RPA-000417
- Atlas verification date
- 2026-11-22
Percentages are copied from the filing without recalculation and use the (A+B+C2) denominator. Compare the original document before using these figures for investment, procurement or governance decisions.
References
- Official company website (as listed in the BSE company record)
- BSE company record: registered office, CIN, ISIN, industry
- NSE XBRL filing: shareholding pattern dated 30 September 2026, Table I
- BSE shareholding pattern: Tables II and III (named holders)
- NSE shareholding-pattern filing index for ENTERO
- GLEIF LEI record
- NSE equity master list (listing date)
- Shareholding pattern dated 30 June 2026
Questions about this company
From the dated Atlas record and official sources.
The filing names 8 public shareholders holding more than 1%: HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND (3.19%), INVESCO INDIA CONTRA FUND (3.19%), SURBHI SINGH(PRASID UNO FAMILY TRUST) (3.05%), 3P INDIA EQUITY FUND 1 (3.03%), BANK OF INDIA FLEXI CAP FUND (2.40%).4 Names appear exactly as filed; a fund scheme name can stand for the fund house’s combined holding. Named holders are part of the public category and must not be added to it.
Within the 47.60% public category, domestic institutions held 21.16%, foreign institutions including portfolio investors 5.77%, central and state governments 0.00% and non-institutional shareholders 20.67% at 30 September 2026.4 These are filing sub-totals of Table III.
